Clinical Trial Update: Safety and Immunogenicity of a Plasmid HIV Vaccine in HIV Uninfected Adults [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immunogenicity of a plasmid HIV vaccine in HIV-uninfected adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Plasmid HIV Vaccine (plasmid DNA HIV vaccine)

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV Infection | Phase 1 | Status: COMPLETED